18F-胆碱PET/CT、MRI及软件图像融合在原发性甲状旁腺功能亢进症中的分析
该回顾性研究纳入42例原发性甲状旁腺功能亢进症患者,评估18F-胆碱PET/CT与MRI的诊断效能及软件图像融合的附加价值。共46个病灶经组织学确认,PET/CT灵敏度93.5%、特异度97.5%,MRI灵敏度39.1%、特异度89.3%,两者检出率差异有统计学意义(P < 0.001)。结论为18F-胆碱PET/CT在定位诊断上明显优于MRI,图像融合有助于更精确的解剖定位。
要点
- 18F-胆碱PET/CT灵敏度93.5%、特异度97.5%,明显优于MRI。
- MRI灵敏度39.1%、特异度89.3%,检出率差异有统计学意义(P < 0.001)。
- 软件图像融合可帮助更精确的解剖定位。
核心结论
- 18F-胆碱PET/CT在原发性甲状旁腺功能亢进症定位诊断中明显优于MRI。
- 两种模态的图像融合有助于更精确的解剖定位。
研究设计与样本
- 回顾性研究纳入42例患者(38例女性),年龄32.5至79.1岁。
- PET/CT在专用系统上注射250至350 MBq 18F-胆碱后进行。
- MRI使用颈部T1加权图像,通过基于互信息的自动算法进行解剖核心gistration实现图像融合。
主要发现
- 42例患者共发现46个病灶并经组织学确认,包括38个腺瘤和8个增生。
- 其中4例患者每人发现2个病灶。
- PET/CT检测到46个异常发现,其中43个正确识别,3个为假阳性。
- PET/CT有3个假阳性和3个假阴性,灵敏度93.5%、特异度97.5%。
- MRI部位特异性评估显示18个真阳性增大甲状旁腺,13个假阳性,漏诊28个病灶,灵敏度39.1%、特异度89.3%。
关键数值与推荐
- PET/CT与MRI检出率差异有统计学意义(P < 0.001)。
临床怎么用
- 18F-胆碱PET/CT可作为原发性甲状旁腺功能亢进症定位诊断的优先影像方法。
- 软件图像融合可辅助更精确的解剖定位。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: The aim of this study was to evaluate the diagnostic performance of 18F-choline PET and MRI in patients with primary hyperparathyroidism. Furthermore, the additional value of software-based PET/MRI scan fusion was analyzed. PATIENTS AND METHODS: This retrospective study includes 42 patients (38 women) with an age between 32.5 and 79.1 years. PET/CT scans were performed on a dedicated system after injection of 250 to 350 MBq 18F-choline. For the MRI examination, T1-weighted images of the cervical region were used. The image fusion was made by anatomical coregistration using an automated algorithm based on mutual information. RESULTS: A total of 46 lesions were discovered and histologically confirmed in 42 patients. Histopathological examination revealed 38 adenomas and 8 hyperplasias. This means that, in 4 of these 42 patients, 2 lesions per patient were discovered. PET/CT also detected 46 abnormal findings, but only 43 were correctly recognized, whereas the other 3 were false-positive (FP). Six lesions could not be detected correctly: 3 were FP and 3 false-negative, which resulted in a sensitivity of 93.5% and a specificity of 97.5%. The site-specific evaluation showed 18 true-positive enlarged parathyroid glands with MRI, but also produced 13 FP findings and failed to detect 28 lesions; the sensitivity and specificity are thus 39.1% and 89.3%, respectively. The difference in detection rate between 18F-choline PET/CT and MRI was statistically significant (P < 0.001). CONCLUSIONS: 18F-choline PET/CT is clearly superior to MRI for localization diagnostics in primary hyperparathyroidism. Image fusion of both modalities can be helpful for more precise anatomical assignment.
引用
- Hofer T, Kronbichler J, Huber H, et al. 18F-Choline PET/CT, MRI, and Software-Based Image Fusion Analysis in Patients With Primary Hyperparathyroidism. Clin Nucl Med. 2021. PMID: 34115700. doi:10.1097/RLU.0000000000003738
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。